CD274 and breast cancer: In a murine model of human breast cancer, blockade of the PD-1/PD-L1 pathway using a monoclonal antibody yielded improved therapeutic efficacy of DC vaccination with prolonged survival and prevention of tumor growth (Ge et al., 2013).